Product Search

VENTOMAX Product Information Leaflets
Brand Name:


Montelukast Sodium is a selective leukotriene receptor antagonist that specifically inhibits the cysteinyl leukotriene (CysLT1) receptor.


Ventomax 5mg chewable tablets: Each tablet contains 5.2mg. Montelukast Sodium equivalent to 5mg Montelukast Acid. Ventomax 10mg tablets: Each tablet contains 10.4mg Montelukast Sodium equivalent to 10mg Montelukast Acid.


Ventomax is indicated for the prophylaxis and chronic treatment of asthma. Ventomax is also indicated for the relief of symptoms of seasonal allergic rhinitis.


Asthma and/or seasonal allergic rhinitis Adults: 15 years of age and older: One 10mg tablet daily Children: 6-14 years of age: One 5mg chewable tablet daily. Safety and efficacy has not been established in pediatric patients younger than 6 years. Reduction in Concomitant Therapy: Bronchodilator Treatments: Ventomax can be added to the treatment regimen of patients who are not adequately controlled on bronchodilator alone. When a clinical response is evident the patient’s bronchodilator therapy can be reduced as tolerated. Inhaled Corticosteroids: Treatment with Ventomax provides additional clinical benefit to patients treated with inhaled corticosteroids. A reduction in the corticosteroid dose can be made as tolerated. The dose should be reduced gradually with medical supervision. Ventomax should not be substituted for inhaled corticosteroids.


Hypersensitivity to any component of this product.


Ventomax 5mg: Blister pack of 14 chewable tablets (2x7) Ventomax 10mg: Blister pack of 14 tablets (2x7)

Patients should consult with their physician before taking any medicine.